NasdaqGS - Nasdaq Real Time Price USD
MeiraGTx Holdings plc (MGTX)
6.49
+0.22
+(3.51%)
At close: 4:00:02 PM EDT
6.49
0.00
(0.00%)
After hours: 4:19:59 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 631,250 | 15 |
| Sales | 143,000 | 4 |
| Net Shares Purchased (Sold) | 488,250 | 19 |
| Total Insider Shares Held | 19.44M | -- |
| % Net Shares Purchased (Sold) | 2.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GIROUX RICHARD Chief Operating Officer | Sale at price 6.00 per share. | Direct | 144,000 | Apr 22, 2025 |
| FORBES ALEXANDRIA Chief Executive Officer | Sale at price 5.34 per share. | Direct | 253,650 | Apr 8, 2025 |
| FORBES ALEXANDRIA Chief Executive Officer | -- | Direct | -- | Feb 21, 2025 |
| ZELDIN ROBERT K Officer | -- | Direct | -- | Feb 21, 2025 |
| GIROUX RICHARD Chief Operating Officer | -- | Direct | -- | Feb 21, 2025 |
| NAYLOR STUART Officer | -- | Direct | -- | Feb 21, 2025 |
| WOLLIN ROBERT J General Counsel | -- | Direct | -- | Feb 21, 2025 |
| GIROUX RICHARD Chief Operating Officer | Sale at price 6.29 per share. | Direct | 150,960 | Jan 21, 2025 |
| FORBES ALEXANDRIA Chief Executive Officer | -- | Direct | -- | Jan 14, 2025 |
| ZELDIN ROBERT K Officer | -- | Direct | -- | Jan 14, 2025 |
| GIROUX RICHARD Chief Operating Officer | -- | Direct | -- | Jan 14, 2025 |
| NAYLOR STUART Officer | -- | Direct | -- | Jan 14, 2025 |
| WOLLIN ROBERT J General Counsel | -- | Direct | -- | Jan 14, 2025 |
| FORBES ALEXANDRIA Chief Executive Officer | Sale at price 6.30 - 6.47 per share. | Direct | 305,343 | Jan 8, 2025 |
| FORBES ALEXANDRIA Chief Executive Officer | -- | Direct | -- | Jan 7, 2025 |
| ZELDIN ROBERT K Officer | -- | Direct | -- | Jan 7, 2025 |
| GIROUX RICHARD Chief Operating Officer | -- | Direct | -- | Jan 7, 2025 |
| NAYLOR STUART Officer | -- | Direct | -- | Jan 7, 2025 |
| WOLLIN ROBERT J General Counsel | -- | Direct | -- | Jan 7, 2025 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.00 per share. | Indirect | 5,000,000 | Aug 12, 2024 |
| INDYK MARTIN Director | -- | Direct | -- | Jun 5, 2024 |
| HARRIS KEITH R Director | -- | Direct | -- | Jun 5, 2024 |
| GIROUX RICHARD Chief Operating Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 28, 2024 |
| FORBES ALEXANDRIA Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Apr 5, 2024 |
| FORBES ALEXANDRIA Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 12, 2024 |
| GIROUX RICHARD Chief Operating Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| FORBES ALEXANDRIA Chief Executive Officer | -- | Direct | -- | Jan 12, 2024 |
| ZELDIN ROBERT K Officer | -- | Direct | -- | Jan 12, 2024 |
| GIROUX RICHARD Chief Operating Officer | -- | Direct | -- | Jan 12, 2024 |
| NAYLOR STUART Officer | -- | Direct | -- | Jan 12, 2024 |
| WOLLIN ROBERT J General Counsel | -- | Direct | -- | Jan 12, 2024 |
| FORBES ALEXANDRIA Chief Executive Officer | -- | Direct | -- | Jan 8, 2024 |
| GIROUX RICHARD Chief Operating Officer | -- | Direct | -- | Jan 8, 2024 |
| NAYLOR STUART Officer | -- | Direct | -- | Jan 8, 2024 |
| ZELDIN ROBERT K Officer | -- | Direct | -- | Jan 5, 2024 |
| WOLLIN ROBERT J General Counsel | -- | Direct | -- | Jan 5, 2024 |
| INDYK MARTIN Director | -- | Direct | -- | Jun 7, 2023 |
| HARRIS KEITH R Director | -- | Direct | -- | Jun 7, 2023 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.75 per share. | Indirect | 25,000,000 | May 5, 2023 |
Related Tickers
ATYR aTyr Pharma, Inc.
3.5200
+1.44%
KRYS Krystal Biotech, Inc.
165.80
-1.78%
RZLT Rezolute, Inc.
3.9700
+27.65%
REPL Replimune Group, Inc.
8.83
+1.38%
ENTA Enanta Pharmaceuticals, Inc.
5.60
+1.82%
RCKT Rocket Pharmaceuticals, Inc.
7.14
+2.44%
DYN Dyne Therapeutics, Inc.
10.78
+8.78%
BPMC Blueprint Medicines Corporation
85.81
+2.88%
RGNX REGENXBIO Inc.
8.87
+13.43%
URGN UroGen Pharma Ltd.
10.20
+1.49%